Monica Else

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

Daniel Catovsky, Estella Matutes, R. F. Bezares et al. · The Lancet · 2007 · 678 citations

Hematological Malignancy, Lymphoid Neoplasia, Oncology +9

Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia

Michael R. Grever, Omar Abdel‐Wahab, Leslie A. Andritsos et al. · Blood · 2016 · 271 citations · Full text

Long‐term follow‐up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis

Monica Else, Claire Dearden, Estella Matutes et al. · British Journal of Haematology · 2009 · 264 citations

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial

David Oscier, Matthew Rose‐Zerilli, Nils Winkelmann et al. · Blood · 2012 · 206 citations

The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia

Claire Dearden, Rachel Wade, Monica Else et al. · Blood · 2007 · 144 citations · Full text